Evaluation of vasomotor reactivity by transcranial Doppler sonography in patients with acute stroke who have symptomatic intracranial and extracranial stenosis

Journal of Ultrasound in Medicine

Volumn 26, Issue 2, 2007, Pages 179-185

  Uzunca, Ilkay ^a   Asil, Talip ^a   Balci, Kemal ^a   Utku, Ufuk ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Large artery atherothrombosis; Transcranial Doppler examination; Vasomotor reactivity

Indexed keywords

BIOMARKERS; BLOOD; DISEASES; DOPPLER EFFECT; NEUROLOGY; ULTRASONIC APPLICATIONS;

DOPPLER SONOGRAPHY; EXTRACRANIAL STENOSIS; LARGE ARTERY ATHEROTHROMBOSIS; TRANSCRANIAL DOPPLER EXAMINATION; VASOMOTOR REACTIVITY (VMR);

PATIENT MONITORING;

ACETAZOLAMIDE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BARTHEL INDEX; BRAIN ARTERY; CLINICAL ARTICLE; CORRELATION ANALYSIS; DOPPLER ECHOGRAPHY; FEMALE; HEMISPHERE; HEMODYNAMICS; HUMAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PROGNOSIS; QUALITY OF LIFE; STROKE; SYMPTOM; VASOMOTOR REFLEX;

EID: 33846683297     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2007.26.2.179     Document Type: Article

References (27)

1. Derdeyn CP, Grubb RL Jr, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology 1999; 53:251-259.
2. Pasternak RC, Criqui MH, Benjamin EJ, et al. Atherosclerotic vascular disease conference. Writing group I: epidemiology. Circulation 2004; 109:2605-2612.
3. Schumacher HC, Khaw AV, Meyzis PM, Gupta R, Higashida RT. Intracranial angioplasty and stent placement for cerebral atherosclerosis. J Vasc Interv Radiol 2004; 15:123-132.
4. Wechsler LR. Cerebrovascular disease. In: Babikian VL, Wechsler LR (eds). Transcranial Doppler Ultrasonography. 2nd ed. Woburn, MA: Butterworth- Heinemann; 1999:91-108.
5. Rajamani K, Gorman M. Trancranial Doppler in stroke. Biomed Pharmocother 2001; 55:246-257.
6. Vernieri F, Pasqualetti P, Matteis M, et al. Effect of collateral blood flow and cerebral vasomotor reactivity on the outcome of carotid artery occlusion. Stroke 2001; 32:1552-1558.
7. Teasdale G, Jennet B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974; 13:81-84.
8. Scandinavian Stroke Study Group, Multicenter trial of hemodilution in ischemic stroke: background and study protocol [editorial]. Stroke 1985; 16:885-890.
9. Mahoney FI, Barthel D. Functional evaluation: the Barthel index. Md State Med J 1965;14:56-61.
10. Beasley MG, Blau JN, Gosling RG. Changes in internal carotid artery flow velocities with cerebral vasodilation and constriction. Stroke 1979; 10:331-335.
11. Ozgür HT, Walsh TK, Masaryk A, et al. Correlation of cerebrovascular reserve as measured by acetazolamide-challenged SPECT with angiographic flow patterns and intra-or extracranial arterial stenosis. J Neuroradiol 2001; 22:928-936.
12. Kazumata K, Tanaka N, Ishikawa T, et al. Dissociation of vasoreactivity to acetazolamide and hypercapnia: comparative study in patients with chronic occlusive major cerebral artery disease. Stroke 1996; 27:2052-2058.
13. Kuroda S, Houkin K, Kamiyama H, et al. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001; 32:2110-2116.
14. Loewen SC, Anderson BA. Predictors of stroke outcome using objective measurement scales. Stroke 1990; 21:56-61.
15. Okudaira Y, Arai H, Sato K. Cerebral blood flow alteration by acetazolamide during carotid balloon occlusion: parameters reflecting cerebral perfusion pressure in the acetazolamide test. Stroke 1996; 27:617-621.
16. Liebeskind, David S. Collateral circulation. Stroke 2003; 34:2279-2284.
17. Bisschops RH, Klijn CJ, Kappelle LJ, van Huffelen AC, van der Grond J. Collateral flow and ischemic brain lesions in patients with unilateral carotid artery occlusion. Neurology 2003; 60:1435-1441.
18. Yokota C, Hasegawa Y, Minematsu K, Yamaguchi T. Effect of acetazolamide reactivity and long-term outcome in patients with major cerebral artery occlusive diseases. Stroke 1998; 29:639-644.
19. Marshall RS, Rundek T, Sproule DM, et al. Monitoring of cerebral vasodilatory capacity with transcranial Doppler carbon dioxide inhalation in patients with severe carotid artery disease. Stroke 2003; 34:945-949.
20. Yamauchi H, Fukuyama H, Nagahama Y, et al. Long-term changes of hemodynamics and metabolism after carotid artery occlusion. Neurology 2000; 54:2095-2102.
21. Okazawa H, Yamauchi H, Sugimoto K, et al. Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. J Cereb Blood Flow Metab 2001; 21:1472-1479.
22. Inao S, Tadokoro M, Nishino M, et al. Neural activation of the brain with hemodynamic insufficiency. J Cereb Blood Flow Metab 1998;18:960-967.
23. Derdeyn CP, Videen TO, Fritsch SM, Carpenter DA, Grubb RL Jr, Powers WJ. Compensatory mechanisms for chronic cerebral hypoperfusion in patients with carotid occlusion. Stroke 1999; 30:1019-1024.
24. Demolis P, Florence G, Thomas L, et al. Is the acetazolomide test valid for quantitative assessment of maximal cerebral autoregulatory vasodilation? An experimental study. Stroke 2000; 31:508-515.
25. Hasegawa Y, Yamaguchi T, Tsuchiya T, Minematsu K, Nishimura T. Sequential change of hemodynamic reserve in patients with major cerebral artery occlusion or severe stenosis. Neuroradiology 1992; 34:15-21.
26. Ogasawara K, Ogawa A, Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke 2002; 33:1857-1862.
27. Vorstrup S. Tomographic cerebral blood flow measurements in patients with ischemic cerebrovascular disease and evaluation of the vasodilatory capacity by the acetazolamide test. Acta Neurol Scand Suppl 1988;114:1-418.